United States Analgesic Infusion Pumps Market Insight
Published: 18 August 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
United States analgesic infusion pumps market is expected to see growth at a CAGR of 11.50%, due to a high rate of adoption of advanced PCA technologies, increasing demand for more focused pain management and opioid-sparing techniques in postoperative and chronic pain treatments, and increasing investments for specialty pain management clinics, ASCs and infusion therapy programs in hospitals.
United States Analgesic Infusion Pumps Market Insight Forecasts to 2035
- The United States Analgesic Infusion Pumps Market Size Was Estimated USD 2,350.0 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 11.50% from 2025 to 2035
- The United States Analgesic Infusion Pumps Market Size is Expected to rise around USD 6,987.6 Million by 2035
Notable Insights for the United States Analgesic Infusion Pumps Market
- The product-based segmentation, the segment of Patient-Controlled Analgesia (PCA) Pumps is the dominant one with a market share of around 54% in the US Analgesic Infusion Pumps Market in 2025 due to their growing utilization in post-operative pain management, analgesia in labor and delivery, and management of chronic cancer pain with the use of on-demand drug delivery.
- The application-based segmentation, the segment of Hospitals & Surgical Centers is the leading one with a market share of approximately 61% in the US Analgesic Infusion Pumps Market in 2025 due to the growing use of smart pump technology, integration with the electronic medical record (EMR), and dose-error reduction system.
- The total revenue of Becton, Dickinson and Company (BD) on a global level for the fiscal year 2025 is estimated to be around $20.6 billion due to high demand for smart infusion system, wireless PCA and integrated medication management system for analgesic delivery applications.
- As per expectations, increasing trend towards automation in healthcare sector with AI-based dose optimization and needs of patient safety in hospitals will fuel market growth in which the analgesic infusion pump technology improves the efficiency in pain management by up to 43% and reduces medication error rate up to 31%.
Download the eBook (ToC)
Research Methodologies Used to Analyze the United States Analgesic Infusion Pumps Market
The United States analgesic infusion pumps market is analyzed by a blend of primary and secondary research approaches for ensuring accurate information about the market and its forecasted performance. Primary research is conducted through discussions with infusion pump manufacturers and distributors, research laboratories, healthcare organizations, pain management firms, and experts to analyze demand trends, technological progress, and competitive activities. Secondary research will involve analyzing reports published by companies and governments, industry journals, scientific papers, import‑export data, and industry organizations in connection with medical devices and pain management industries. Market estimation, trend analysis, and forecasting methods will be used for estimating market size, growth opportunities, price dynamics, and investments.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United States Analgesic Infusion Pumps Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United States Analgesic Infusion Pumps Market
- Becton, Dickinson and Company (BD)
- Baxter International Inc.
- ICU Medical, Inc.
- B. Braun Melsungen AG
- Smiths Medical (Smiths Group plc)
- Moog Inc.
- Medtronic plc
- Fresenius Kabi AG
- Terumo Corporation
- Zyno Medical, LLC
Recent Developments:
- In April 2026, Becton, Dickinson and Company (BD) signed an agreement with leading United States hospital network for expanding the deployment of next generation wireless PCA pumps with EMR integration and dose-error reduction AI software for major surgery centers in the Northeast.
- In November 2025, ICU Medical, Inc. launched next generation smart infusion systems with integrated real-time drug library management, dose calculation and predictive analytics capabilities.
Market Segmentation:
United States Analgesic Infusion Pumps Market, By Product Type
- Patient-Controlled Analgesia (PCA) Pumps
- Epidural Infusion Pumps
- Continuous Peripheral Nerve Block Pumps
- Subcutaneous Infusion Pumps
- Intrathecal Infusion Pumps
United States Analgesic Infusion Pumps Market, By Technology
- AI‑Based Dose Optimization & Predictive Analytics
- Wireless & Bluetooth‑Enabled Smart Pumps
- EMR‑Integrated Infusion Management Systems
- Real‑Time Remote Patient Monitoring Solutions
- Automated Drug Library & Safety Guard Technologies
United States Analgesic Infusion Pumps Market, By Application
- Postoperative Pain Management
- Chronic Pain Management (Cancer & Non-Cancer)
- Labor & Delivery Analgesia
- Trauma & Emergency Pain Control
- Orthopedic & Sports Medicine Pain Therapy
Expert Views:
The growth of analgesic infusion pumps markets in the United States is expected to be supported by the usage of sophisticated smart pump devices, increasing number of surgeries and pain management cases, and higher demand for selective pain management strategies that avoid the use of opioids. The development of AI-based dose adjustment systems, EMR-based drug management processes, and real-time patient monitoring systems would help enhance the efficiency of pain management and increase the demand for such products within hospital surgical wards, ASCs, pain management clinics, and home care settings in the United States
Author: Govind and Krishna By Decisions Advisors and Consulting